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Summary
We present a two-stage genomewide scan for osteoar-
thritis-susceptibility loci, using 481 families that each
contain at least one affected sibling pair. The first stage,
with 272 microsatellite markers and 297 families, in-
volved a sparse map covering 23 chromosomes at in-
tervals of ∼15 cM. Sixteenmarkers that showed evidence
of linkage at nominal were then taken throughP  .05
to the second stage, with an additional 184 families. This
second stage confirmed evidence of linkage for markers
on chromosome 11q. Additional markers from this re-
gion were then typed to create a denser map. We ob-
tained a maximum single-point LOD score, at D11S901,
of 2.40 ( ) and a maximum multipoint-LODP  .0004
score of 3.15, between markers D11S1358 and D11S35.
A subset of 196 of the 481 families, comprising affected
female sibling pairs, generated a corrected LOD score
of 2.54 ( ) for marker D11S901, with evidenceP  .0003
for linkage extending 12 cM proximal to this marker.
When we stratified for affected male sibling pairs there
was no evidence of linkage to chromosome 11. Our data
suggest that a female-specific susceptibility gene for id-
iopathic osteoarthritis is located on chromosome 11q.
Introduction
Osteoarthritis (MIM 165720) is a common debilitating
disease involving degeneration of the articular cartilage
of synovial joints (Creamer and Hochberg 1997). Early-
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onset forms of the disease are associated with several
osteochondrodysplasias—rare diseases involving abnor-
mal bone and cartilage development that are transmitted
as Mendelian traits (Horton 1996). The osteoarthritis
in these conditions is secondary to the main dysplastic
phenotype. The common late-onset form of the disease
(idiopathic osteoarthritis) often has no obvious environ-
mental or characteristic physical cause. Although idio-
pathic osteoarthritis has long been considered an inev-
itable consequence of aging, a strong genetic component
has been demonstrated (Felson et al. 1998; Hirsch et al.
1998). A twin study has estimated that the heritability
of radiographic osteoarthritis of the hand and knee
shows a range of 39%–65% (Spector et al. 1996), and
relative-risk calculations have revealed that first-degree
relatives of individuals who have had hip- or knee-
joint–replacement surgery for osteoarthritis have a
2.3-fold increased risk of developing end-stage disease
(Chitnavis et al. 1997). Idiopathic osteoarthritis does not
demonstrate a clear mode of inheritance and can be clas-
sified as a complex multifactorial disease.
A number of candidate genes have been proposed as
potential susceptibility loci for idiopathic osteoarthritis,
but the results from different studies have tended to be
conflicting (Vikkula et al. 1993; Loughlin et al. 1994;
Uitterlinden et al. 1997; Aerssens et al. 1998). This may
simply be a reflection of the complexity of the disease.
Alternatively, this conflict may highlight the limited
power of some of the studies performed. The patho-
physiology of osteoarthritis is complex, and the choice
of candidate genes is prone to personal bias. Overall,
therefore, we felt that the genetic dissection of idiopathic
osteoarthritis merited a systematic genome screen using
anonymous polymorphic microsatellite markers. To test
for linkage, we used an affected sibling–pair approach
and recruited affected sib pairs, using joint-replacement
surgery resulting from idiopathic osteoarthritis as our
ascertainment criterion. Our aim was to use families
whose idiopathic osteoarthritis was severe and therefore
more likely to have a genetic component. We used a
two-stage approach, similar to that proposed by Hol-




Type of Affectation Stage 1 Stage 2 Total
Total no. of families: 297 184 481
With affected sibling pairs 265 149 414
With affected sibling trios 23 28 51
With affected sibling quartets 7 5 12
With othera 2 2 4
Stratified:
Total no. of women 132 64 196
Pair 120 57 177
Trio 12 7 19
Total no. of men 60 42 102
Pair 55 37 92
Trio 4 5 9
Othera 1 0 1
Total no. of THR 194 117 311
Pair 170 94 264
Trio 17 19 36
Quartet 5 2 7
Othera 2 2 4
Total no. of TKR 34 20 54
Pair 33 19 52
Trio 1 1 2
Total no. of female THR 85 47 132
Pair 77 46 123
Trio 8 1 9
Total no. of female TKR 16 5 21
Pair 16 5 21
Total no. of male THR 44 27 71
Pair 40 25 65
Trio 3 2 5
Othera 1 0 1
Total no. of male TKR 4 4 8
Pair 4 4 8
Total no. of affected individuals: 641 413 1,054
Women 394 231 625
Men 247 182 429
Stratified:
No. of THR 479 311 790
No. of TKR 121 77 198
No. of hip and knee 41 25 66
No. of female THR 287 173 460
No. of female TKR 77 42 119
No. of female hip and knee 30 16 46
No. of male THR 192 138 330
No. of male TKR 44 35 79
No. of male hip and knee 11 9 20
No. of additional siblings: 211 91 302
Women 107 49 156
Men 104 42 146
a Pairs of relatives, such as cousins, uncles, and aunts.
mans and Craddock (1997). In stage 1 we genotyped
272 microsatellite markers in 297 of 481 families. In
stage 2, microsatellites that demonstrated evidence for
linkage at nominal in these 297 families wereP  .05
then analyzed in the remaining 184 families. This two-
stage approach demonstrated linkage of markers on 11q
to idiopathic osteoarthritis. Additional 11q markers
were then typed to create a finer linkage map of this
region. Stratification revealed that linkage was restricted
to affected female sib pairs.
Families and Methods
Osteoarthritis Families
Families with at least two siblings each of whom had
undergone one or more replacements of the total hip
(THR), the total knee (TKR), or both, for primary idi-
opathic osteoarthritis, were recruited (table 1). Of the
790 individuals who had undergone only THR, 31.4%
had undergone THR of the right hip and 22.7% had
undergone THR of the left hip, whereas 45.9% had
undergone bilateral THR. Of the 198 individuals who
had undergone only TKR, 30.0% had undergone TKR
of the right knee and 23.5% had undergone TKR of the
left knee, whereas 46.5% had undergone bilateral TKR.
Of the 66 individuals who had undergone hip and knee
replacement, only 9 (13.6%) had undergone bilateral
THR and bilateral TKR. Heberden’s nodes were present
in 38.5% of our affected individuals. The majority
(58.3%) of these individuals had at most three nodes.
The collection of families was undertaken through the
Nuffield Orthopaedic Centre in Oxford, the Musgrave
Park Hospital in Belfast, and the Wishbone Trust Char-
ity, which is part of the British Orthopaedic Association.
The patients were reviewed and examined by trained
clinical research nurses. Radiographs and, when avail-
able, histological samples were reviewed. We excluded
all cases other than primary idiopathic osteoarthritis.
Idiopathic osteoarthritis is typically a late-onset disease,
and parents of affected siblings are rarely available. Of
the 481 families recruited, only 3 had a parent who was
able to participate. We therefore collected additional sib-
lings who had not undergone THR or TKR, to assist in
the determination of identical-by-descent (IBD) allele
transmittance. The 481 families comprised 1,054 af-
fected individuals plus 302 additional siblings. Of the
affected individuals 625 (59.3%) were women and 429
(40.7%) were men. The average age of the affected in-
dividuals at the time of their first operation was 66 years
( years), with an average age of 66 yearsSD  9.0
( years) in affected women and an average ageSD  9.3
of 65 years ( years) in affected men. From eachSD  8.6
individual, 25 ml of venous blood was collected into
EDTA tubes, and DNA was extracted by conventional
techniques. Ethical approval for the study was obtained
from the Central Oxford Research Ethics Committee,
and informed consent was obtained from all subjects.
Markers and Genotyping
Our initial screening panel consisted of 292 micro-
satellite markers and was essentially the panel used by
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Reed et al. (1994). Twenty (7%) of these markers am-
plified unreliably and were eliminated from the study.
These 20 markers were spread across 14 of the 23 chro-
mosomes. The additional microsatellite markers used to
provide denser coverage of chromosome 11 were ob-
tained from the Genome Database or from the Prism
Linkage Mapping Set (version 2; Applied Biosystems).
The markers were amplified with either the forward or
the reverse primer in a PCR pair fluorescently labeled.
The amplification products were electrophoresed
through 6% acrylamide with automated DNA sequenc-
ers (ABI model 377; Applied Biosystems). We sized al-
leles, using GENESCAN (2.0.2) and GENOTYPER (1.1)
software (Applied Biosystems). A list of the markers used
and the results obtained are available electronically from
the Wellcome Trust Centre for Human Genetics website.
Linkage Analysis
Since parents were rarely available to verify IBD, ex-
tensive error-checking procedures were employed for all
families, for each marker. After we identified straight-
forward misinheritances, more-subtle transmission er-
rors were detected by PEDCHECK (O’Connell and
Weeks 1998). The entire family-data set was tested with
RELATIVE (Goring and Ott 1997). RELATIVE tests
whether the proportion of alleles shared IBD at unlinked
loci (on the basis of 50 markers) is consistent with the
expected proportion for each relative pair, thus allowing
the identification of probable MZ twins, half-sibs, or
unrelateds (as a result of unknown adoption or labo-
ratory error). All 481 families analyzed in the study suc-
cessfully progressed through these checks. In addition,
the data were scrutinized for the presence of an excess
of homozygotes among the genotypes produced with
each marker, on the basis of allele frequencies and
Hardy-Weinberg predictions (RECODE, version 1.4; D.
Weeks, personal communication). Markers considered
to be unreliable were eliminated from the study.
Linkage analysis was performed with the SIBPAIR
module of the ANALYZE package (Terwilliger 1996).
This module is able to use data from siblings to estimate
IBD allele transmittance. In the linkage analysis, siblings
who had not undergone joint replacement were given a
clinical status of “unknown.” The SIBPAIR module pro-
duces a single-point LOD score and its asymptotic P
value. Allele frequencies were calculated from the input
data by GAS (Oxford University Computing Services).
Subsequent multipoint analyses were performed with
ASPEX, which calculates its own allele frequencies from
the data set by use of a maximum-likelihood method
and employs marker information across the chromo-
some simultaneously. ASPEX produces a maximum mul-
tipoint-LOD score (MLS) under an additive model. It
also produces an exclusion map along the entire chro-
mosome, on the basis of a fixed value for sibling relative
risk (l). To estimate the influence that allele frequencies
on the linkage to chromosome 11 have, we ran the link-
age analyses through the following artificially created
sets of allele frequencies: (1) alleles that were of equal
frequency; (2) alleles that had a frequency ! .1, which
were binned together; and (3) alleles that were assigned
frequency values either on the basis of the founders from
each pedigree or (where no founders existed) on the basis
of individuals selected at random from the pedigree (RE-
CODE, version 1.4).
Our linkage-analysis strategy was to genotype a sparse
map in a first stage containing 297 of our 481 families.
Any marker that had a nominal P value .05 in stage
1 would then be examined in the remaining 184 families
(stage 2). The aim of this strategy was to take through
to stage 2 only those markers that demonstrated rea-
sonable evidence of linkage (Holmans and Craddock
1997). In stage 2 we were not necessarily expecting to
repeat any of the positive linkage results of stage 1 but,
instead, were looking for further evidence of linkage,
even if only moderate. If a marker’s P value for stages
one and two combined was no more than the P value
for stage 1, then it would support linkage at that marker.
There was no difference in the ascertainment criteria
between the stage 1 and stage 2 families; once a rea-
sonably large number of families had been collected, we
began the first stage of our linkage strategy.
Stratification
We stratified by sex, joint replaced (hip or knee), and
both sex and joint replaced. For those families with more
than two affected siblings and in which the siblings were
not all of the same sex, the affected sibling(s) of opposite
sex to a same-sex pair were given an affected status of
“unknown” in the linkage analysis.
A “hip-only pair” comprised siblings who had each
undergone THR (uni- or bilateral), whereas a “knee-
only pair” comprised siblings who had undergone TKR
(uni- or bilateral). If an affected pair comprised one sib-
ling who had undergone joint replacement of only one
type of joint (hip or knee), whereas the affected sibling
had undergone joint replacement of the hip and knee,
then that pair was excluded. For an affected trio, if a
pair of the siblings had undergone joint replacement of
the same joint type only (hip or knee), whereas the third
sibling had undergone both hip and knee replacement,
then the concordant pair were used in the stratification
study and the third sibling was given a status of “un-
known” in the linkage analysis.
We adjusted LOD scores and P values to correct for
the six strata tested (women only, men only, hips only,
knees only, female hip, and male hip). For a corrected
LOD we deducted from the original LODlog6  0.78
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Table 2
Markers with Evidence for Linkage in Stage 1
MARKER








D2S202 .036a .70 .07 .49 .009a 1.21
D3S1266 .017a .96 .5 ) .082 .42
D4S231 .040a .67 .5 ) .33 .04
D4S415 .018a .95 .33 .04 .025a .83
D6S260 .050a .58 .5 ) .13 .29
D6S273 .016a .98 .5 ) .077 .44
D6S286 .030a .77 .5 ) .081 .42
D6S281 .046a .61 .45 ) .062 .52
D7S669 .018a .94 .25 .10 .021a .90
D7S530 .006a 1.36 .41 .01 .013a 1.09
D11S907 .050a .58 .12 .31 .025a .84
D11S903 .017a .97 .07 .49 .007a 1.32
D11S901 .0004a 2.45 .10 .37 .0004a 2.40
D17S807 .014a 1.03 .5 ) .15 .24
D17S789 .010a 1.16 .5 ) .071 .47
DXS1068 .024a .84 .5 ) .10 .35
NOTE.—Nominal P values and LOD scores for all markers
that had .P  .05
a .P  .05
Table 3









D11S4046 4 .36 .03 .51 .85
D11S907 51 .025a .84 .54 .67
D11S903 64 .007a 1.32 .55 .73
D11S4191 69 .01 .35 .52 .84
D11S1883 73 .50 ) .50 .73
D11S1314 82 .006a 1.36 .55 .76
D11S916 85 .012a 1.12 .54 .80
D11S937 89 .077 .44 .52 .89
D11S901 94 .0004a 2.40 .56 .80
D11S1342 101 .034a .72 .54 .67
D11S1358 102 .066 .49 .53 .69
D11S35 110 .10 .36 .52 .76
D11S898 110 .058 .53 .53 .76
D11S908 121 .50 ) .50 .65
D11S925 133 .096 .37 .52 .81
D11S4089 134 .50 ) .50 .72
D11S1320 157 .50 ) .50 .59
a .P  .05
score, whereas for a corrected P value we increased the
original P value sixfold (Kidd and Ott 1984).
Results
Sixteen markers from stage 1 showed evidence of link-
age at a nominal P value .05 (table 2). These markers
were then genotyped in the remaining 184 families of
stage 2. None of the 16 markers had a nominal P value
.05 in this second stage, although three had :P  .10
D2S202 ( ), D11S903 ( ), and D11S901P  .07 P  .07
( ) (table 2). When the data for stages 1 and 2P  .10
were combined and compared with those for stage 1
only, the combined P value decreased for 3 of the 16
markers: D2S202 ( for combined vs.P  .009 P 
for stage 1), D11S907 ( for combined vs..036 P  .025
for stage 1), and D11S903 ( for com-P  .05 P  .007
bined vs. for stage 1); for D11S901 the P valueP  .017
was unchanged ( ). Increasing the number ofP  .0004
families therefore increased or supported the evidence
for linkage at these four markers. Since three of the four
markers were on chromosome 11, we concentrated our
analysis on this chromosome.
The three chromosome 11 markers that had nominal
P values .05 in the combined data set encompass ∼55
cM of the chromosome. Most of the chromosome 11
markers from stage 1 were not taken through to stage
2 because they did not reach our linkage criterion of
. Two of these markers immediately flanked theP  .05
55-cM region, and one was located within it. These three
markers were genotyped in the 184 families of stage 2.
To provide denser coverage of the chromosome we also
genotyped 11 new markers, located within and around
this 55-cM region, for all 481 families. This made a total
of 17 markers covering 153 cM of chromosome 11, at
a mean density of ∼1 marker/9 cM (table 3). The lowest
P value remained with marker D11S901 (.0004). A mul-
tipoint analysis gave an MLS of 3.15, distal to D11S901
and between markers D11S1358 and D11S35 (fig. 1).
An estimate of the contribution of the chromosome 11
locus to osteoarthritis can be calculated from l for this
locus. The l for D11S901 is 1.3 (mean IBD estimate of
.56, with z0 [the proportion of sib pairs sharing neither
allele IBD] of .19]. In the British population the l for
osteoarthritis, ascertained through joint-replacement
surgery, has been determined to be 2.3 (Chitnavis et al.
1997). Therefore, under an additive model the contri-
bution of the chromosome 11 locus may be as large as
23% ([1.31.0]/[2.31.0]), whereas under a nonaddi-
tive model the contribution may be as large as 31% (log
1.3/log 2.3) (Risch 1990; Hager et al. 1998). A sensitivity
analysis determined that the linkage on chromosome 11
was robust to misspecification of allele frequencies (data
not shown).
Stratification
It has often been noted in epidemiological studies that
there is a preponderance of osteoarthritis in women
(Creamer and Hochberg 1997). This may be due to dif-
ferential effects that environmental factors have on the
two sexes. However, a Finnish study in twins has sug-
gested that genetic susceptibility may be greater in
women than in men (Kaprio et al. 1996), and this result
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Figure 1 Multipoint analysis of chromosome 11, for stages 1
and 2 combined.
has been supported by a segregation analysis (Felson et
al. 1998). Not only have differences in heritability be-
tween women and men been reported, but it also has
been suggested that there are heritability differences be-
tween groups defined by type of affected joint (Lindberg
1986; Cooper et al. 1994; Chitnavis et al. 1997). These
differences may be the result of genetic-locus heteroge-
neity. On the basis of these studies, we stratified our
results for chromosome 11 into six categories: affected
women only (196 families), affected men only (102 fam-
ilies), hips only (men, women, or both; 311 families),
knees only (men, women, or both; 54 families), affected
women who had undergone THR but not TKR (female
THR; 132 families), and affected men who had under-
gone THR but notTKR (male THR; 71 families) (table
1). We did not stratify for female TKR or male TKR,
because the number of families was too low (21 and 8,
respectively) to allow reliable inference of linkage.
This stratification analysis revealed that the linkage to
chromosome 11 was predominantly accounted for by
the affected women–only pairs, with a single-point LOD
score of 2.54 ( , mean IBD estimate of .62) forP  .0003
marker D11S901 (table 4) (LOD scores and P values
were corrected for the six stratification tests performed).
Only one marker flanking D11S901 also supported link-
age in women-only pairs at : D11S1314 (P  .05 P 
), 12 cM proximal to D11S901. The MLS for.036
women-only pairs was 2.81, between markers D11S901
and D11S1342 (fig. 2A). For affected men–only pairs
there was no evidence of linkage either at D11S901
( ) or with any of the markers distal or proximalP  .5
to D11S901. At D11S901 there was much greater evi-
dence for linkage in hip-only pairs ( ) than inP  .0024
knee-only pairs ( ). Two markers proximal toP  .5
D11S901 also supported linkage in hip-only pairs:
D11S1314 ( ) and D11S916 ( ). TheP  .012 P  .0054
MLS in hip-only pairs was 2.58, again between markers
D11S901 and D11S1342 (fig. 2B). In female THR pairs
the P value for D11S901 was .006, compared with .50
in male THR pairs. The MLS in female THR pairs was
3.03, between markers D11S1314 and D11S916 (fig.
2C). Overall, these results suggest that the linkage to
chromosome 11 in our families is restricted to women
with osteoarthritis. In our cohort there are a greater
number of affected women–only pairs than affected
men–only pairs (196 families vs. 102 families; table 1),
which would provide the women-only pairs with greater
power for detection of linkage; however, the difference,
in LOD scores, between the two subsets is striking. An-
other factor that could affect power is the informative-
ness of the families and the degree to which IBD status
can be determined, which is influenced by the number
of siblings typed who are given an “unknown” clinical
status. There was, however, no significant difference in
these numbers between the women-only and men-only
pairs (data not shown). Furthermore, the PIC values for
marker D11S901 in the women-only and men-only pairs
were not significantly different (.81 vs. .80). Of our 481
families, 185 were affected pairs that contained an af-
fected brother and affected sister and so were not used
in the stratification analysis. Linkage to D11S901 was
not significant in these affected pairs ( ,P  .17
, both uncorrected; ). Overall,LOD  0.31 PIC  .80
these results suggest that the specific nature of the 11q
linkage, with its restriction to women-only pairs, is not
an artifact of power differences between the strata. Re-
garding the apparent linkage differences between hip-
only and knee-only pairs, there are substantially more
hip-only families than knee-only families (311 vs. 54),
which could account for our inability to detect linkage
in our knee-only subset.
Discussion
We have identified on chromosome 11q a region that
is likely to contain a osteoarthritis-susceptibility locus.
We used a two-stage approach, similar to that suggested
by Holmans and Craddock (1997). In the first stage we
genotyped 272 microsatellite markers in 297 families
with osteoarthritis. Sixteen markers that showed evi-
dence of linkage at nominal were then takenP  .05
through to the second stage, with an additional 184
families. This second stage confirmed evidence of linkage
for markers on chromosome 11q. Additional markers
were then typed to create a denser map of this region.
For the three genome-screen markers that supported
linkage to this region in stage 1, the evidence for linkage
increased (D11S907 and D11S903) or was unaltered
(D11S901) when the stage 2 families were genotyped
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Figure 2 Multipoint analysis of chromosome 11 for stages 1 and 2 combined, with data stratified. A, Female-only pairs ( families).n  196
B, THR pairs ( ). C, female THR pairs ( ).n  311 n  132
and combined with the stage 1 families. This phenom-
enon was also observed for one other genome marker,
D2S202. Interestingly, the chromosome 2 region to
which this marker maps (2q31-q32.1) has previously
been identified as a region that may harbor an osteo-
arthritis-susceptibility locus (Wright et al. 1996).
Our affected women–only pairs appear to account for
the linkage at 11q, with a corrected P value of .0003
( ) at D11S901, compared with .50LOD  2.54
( ) in men-only pairs. As mentioned earlier,LOD  0.00
it has been suggested that the heritability of osteoar-
thritis is greater in women than in men (Kaprio et al.
1996; Felson et al. 1998). This difference, if real, may
be because one or more of the osteoarthritis-suscepti-
bility loci acts in a hormonal pathway, is under some
degree of hormonal regulation, or both. This observa-
tion could assist in the selection of candidate genes, once
linkage to a particular region of the genome has been
established. It is plausible that a hormonally regulated
system, such as bone mass, is involved in osteoarthritis.
Although osteoarthritis is primarily characterized by de-
generation of articular cartilage, the pathophysiology of
the disease is complex, with numerous cellular and ex-
tracellular changes in bone and cartilage metabolism.
One finding commonly observed is an increase in the
density and mass of the subchondral bone below the
articulating cartilage (Lane and Nevitt 1994; Dequeker
et al. 1997; Mansell and Bailey 1998). This has led to
the suggestions that increased bone mass precedes any
other gross changes in the osteoarthritic joint and that
cartilage loss is a factor that is only secondary to this
change. Under this assumption, genes that influence
bone mass can be considered as candidates for osteo-
arthritis-susceptibility loci. Bone mass is under substan-
tial hormonal regulation, as demonstrated by the effect
that menopause has on both bone mass and the increase
in osteoporotic-fracture risk in older women. A locus
that is a regulator of bone mass has been mapped to
chromosome 11q12-13, and this locus maps to the re-
gion where we have detected linkage (Gong et al. 1996;
Johnson et al. 1997; Heaney et al. 1998; Koller et al.
1998).
A second locus that is on 11q and could be considered
a candidate for osteoarthritis is a matrix metalloprotein-
ase (MMP) gene cluster. MMPs are responsible for ex-
tracellular-matrix degradation and remodeling (Matri-
sian 1992). The 11q cluster consists of at least seven
MMP genes (Pendas et al. 1996). However, this cluster
maps to 11q22.3, which places it 50 cM distal to
D11S901 (11q13.2-13.3). It is unlikely therefore that
this cluster represents the 11q osteoarthritis-susceptibil-
ity locus.
Deloukas et al. (1998) have reported a physical map
of 30,000 human genes (GeneMap 98), which can be
accessed through the World Wide Web. A search of this
database reveals a large number of expressed sequence
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D11S4046 4 .50 ) .15 .05 .50 ) .50 ) .50 ) .03a .67
D11S907 51 .50 ) .50 ) .30 ) .50 ) .50 ) .50 )
D11S903 64 .50 ) .50 ) .50 ) .50 ) .50 ) .50 )
D11S4191 69 .41 ) .50 ) .50 ) .50 ) .50 ) .50 )
D11S1883 73 .50 ) .50 ) .50 ) .50 ) .50 ) .50 )
D11S1314 82 .036a .59 .50 ) .012a 1.04 .50 ) .012a .95 .50 )
D11S916 85 .09 .24 .50 ) .0054a 1.34 .50 ) .024a .77 .50 )
D11S937 89 .09 .25 .50 ) .09 .24 .50 ) .11 .16 .50 )
D11S901 94 .0003a 2.54 .50 ) .0024a 1.67 .50 ) .006a 1.26 .50 )
D11S1342 101 .11 .16 .50 ) .50 ) .26 ) .50 ) .50 )
D11S1358 102 .09 .24 .50 ) .50 ) .50 ) .13 .11 .50 )
D11S35 110 .50 ) .40 ) .50 ) .50 ) .23 ) .46 )
D11S898 110 .38 ) .50 ) .22 ) .50 ) .17 ) .50 )
D11S908 121 .50 ) .50 ) .50 ) .50 ) .50 ) .50 )
D11S925 133 .50 ) .48 ) .50 ) .50 ) .50 ) .50 )
D11S4089 134 .50 ) .26 ) .50 ) .50 ) .50 ) .12 .13
D11S1320 157 .50 ) .50 ) .50 ) .50 ) .50 ) .50 )
NOTE.—P values and LOD scores are corrected to account for the six strata tested.
a .P  .05
tags (ESTs) that map to 11q. These are a starting point
for the identification of single-nucleotide polymor-
phisms, which can be used to narrow the interval and
to define the osteoarthritis locus more precisely. In ad-
dition, mutation analyses of candidate genes derived
from these ESTs can take place concurrently with at-
tempts at fine mapping.
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